• Emmanuel Martinod, Alexandre D'Audiffret, Pascal Thomas, Alain J Wurtz, Marcel Dahan, Marc Riquet, Antoine Dujon, René Jancovici, Roger Giudicelli, Pierre Fuentes, and Jacques F Azorin.
• Department of Thoracic and Vascular Surgery, Hôpital Avicenne, Bobigny, France. emartinod@wanadoo.fr
• Ann. Thorac. Surg. 2002 May 1;73(5):1534-9; discussion 1539-40.

BackgroundThe management of non-small cell carcinomas of the lung involving the superior sulcus remains controversial. The goal of this retrospective study was to evaluate the role of surgery, radiotherapy, and chemotherapy for the treatment of superior sulcus tumors, to define the best surgical approach for radical resection, and to identify factors influencing long-term survival.MethodsBetween 1983 and 1999, 139 patients underwent surgical resection of superior sulcus tumors in seven thoracic surgery centers. According to the classification of the American Joint Committee, 51.1% of cancers were stage IIB, 13.7% stage IIIA, 32.4% stage IIIB, and 2.9% stage IV.ResultsThe resections were performed with 74.1% using the posterior approach and 25.9% using an anterior approach. A lobectomy was accomplished in 69.8% of the cases and a wedge resection in 22.3%. Resection of a segment of vertebrae or subclavian artery was performed, respectively, in 19.4% and 18% of the cases. Resection was complete in 81.3% of cancers. The overall 5-year survival rate was 35%. Preoperative radiotherapy improved 5-year survival for stages IIB-IIIA. Surgical approach, postoperative radiotherapy, or chemotherapy did not change survival.ConclusionsThe optimal treatment for superior sulcus tumors is complete surgical resection. The surgical approach (anterior/posterior) did not influence the 5-year survival rate. Preoperative radiotherapy should be recommended to improve outcome of patients with a superior sulcus tumor.

24 keywords...

hide…